Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification
International Center for Ethnobotanical Education, Research, and Service
Lamotrigine for Ketamine Dependence Trial
Taipei City Hospital
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
Effects of MDMA on Social and Emotional Processing
University of Chicago
The Effects of Sedatives on Tobacco Use Disorder Version 2
Wake Forest University Health Sciences
Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction
Dr. med. Marcus Herdener
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
Anders Fink-Jensen, MD, DMSci
MDMA for Co-occurring PTSD and OUD After Childbirth
University of New Mexico
Ketamine for Combined Depression and Alcohol Use Disorder
University Hospital of North Norway
Open-Label Psilocybin Study in Transdiagnostic Population
Yale University
Psilocybin in Alcohol Use Disorder With Comorbid Depression
Centre Hospitalier Universitaire de Nīmes
Psilocybin for Methamphetamine Addiction
Kevin Murnane
Addiction in Intensive Cardiac Care Units
Assistance Publique - Hôpitaux de Paris
Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
Anders Fink-Jensen, MD, DMSci
How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
Read the trial details, eligibility criteria, and what participation involves.
Reach out to the study team using the contact information provided.
Complete the screening process to determine if you're eligible.